Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 7, 2021; 27(45): 7801-7812
Published online Dec 7, 2021. doi: 10.3748/wjg.v27.i45.7801
Published online Dec 7, 2021. doi: 10.3748/wjg.v27.i45.7801
Table 2 Gene enrichment analysis of decreased microRNAs in ulcerative colitis patients compared with Crohn’s disease patients
Pathway | P value | FDR |
Proteoglycans in cancer | 2.27E-11 | 6.99E-09 |
FoxO signaling pathway | 2.37E-11 | 3.64E-09 |
Pathways in cancer | 7.49E-11 | 7.69E-09 |
Colorectal cancer | 1.25E-07 | 5.51E-06 |
TGF-β signaling pathway | 1.47E-07 | 4.53E-06 |
Signaling pathways regulating pluripotency of stem cells | 4.72E-07 | 1.32E-05 |
Autophagy | 5.58E-07 | 1.32E-05 |
ErbB signaling pathway | 9.95E-07 | 2.19E-05 |
mTOR signaling pathway | 3.70E-06 | 7.61E-05 |
MAPK signaling pathway | 1.66E-05 | 2.22E-04 |
- Citation: Quaglio AEV, Santaella FJ, Rodrigues MAM, Sassaki LY, Di Stasi LC. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers. World J Gastroenterol 2021; 27(45): 7801-7812
- URL: https://www.wjgnet.com/1007-9327/full/v27/i45/7801.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i45.7801